Skip Navigation

Publications

Kachur E, Roshdy D, Hamadeh I, Dodd B, Shahid Z. Single-center experience with use of letermovir for treatment of CMV infection in stem cell transplant recipients. Transpl Infect Dis 2020;23(2):e13502.

Roshdy D, McCarter M, Meredith J, et al. Implementation of a comprehensive intervention focused on hospitalized patients with HIV by an existing stewardship program: successes and lessons learned. Therapeutic Advances in Infectious Disease. January 2021.

Ackley R, Roshdy D, Meredith J, Minor S, Anderson W, Capraro J, Polk C. Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections. Antimicrobial Agents and Chemotherapy Feb 2020, AAC.02313-19

Polk C, Sampson M, Roshdy D, Davidson L. Skin and soft tissue infections in patients with diabetes mellitus. Infect Dis Clin N Am 2021;35(1):183-197.

Quinn N, Roshdy D, Sebaaly J, Patel B, Anderson W, Weinrib D. Effectiveness of oral antibiotics for definitive therapy of non-staphylococcal Gram-Positive bacterial bloodstream infections. Ther Adv Infect Dis 2019;6:1-12.

Roshdy D, Jaffa R, Pillinger KE, Rozario N, Guffey J, Davidson L, McCurdy L. Effect of a multifaceted stewardship intervention of antibiotic prescribing and outcomes for acute bacterial skin and skin structure infections. Ther Adv Infect Dis 2018;5(6):103-109.

Roshdy D, Pillinger KE, Jaffa R, Pasquale TR. C. difficile lives up to its name – The need for systematic approaches for treatment and prevention of future recurrence. Infect Dis Clin Prac 2018;26(2):57-59.

Dellabella A, Roshdy D, Martin KE. High incidence of adverse effects with extended use of ceftaroline. Ann Pharmacother 2016;50(12):1068-9.

Pasquale TR, Roshdy D, Pillinger KE. Structured drug allergy assessment as a primary stewardship intervention? [editorial commentary] Infect Dis Clin Prac 2016;24(6):293-4.

Martin KE, Roshdy D, Kasbekar R, Pasquale TR. Use of risk stratification tools to enhance antimicrobial stewardship practices. Infect Dis Clin Prac 2016;24:204-9.

Roshdy DG, Tran A, LeCroy N, Zeng D, Ou FS, Daniels LM, Weber DJ, Alby K, Miller MB. Impact of a Rapid Microarray Assay for Identification of Positive Blood Cultures on Treatment Optimization for Patients with Streptococcal and Enterococcal Bacteremia. J Clin Microbiol 2015;53(4):1411-4.

Berger O, Rector K, Meredith J, Sebaaly J. Evaluation of Drug-Drug Interactions in Hospitalized Patients on Medications for Opioid Use Disorder. Ment Health Clin June 2021 [Internet]

Meredith J, Onsrud J, Davidson L, Medaris L, Kowalkowski M, Fischer K, Priem J, Leonard M, McCurdy L, Successful Use of Telemedicine Infectious Diseases Consultation with an Antimicrobial Stewardship-Led Staphylococcus aureus Bacteremia Care Bundle, Open Forum Infectious Diseases, 2021;, ofab229, https://doi.org/10.1093/ofid/ofab229

Polk, C., Meredith, J., Kuprenas, A. et al. Cryptococcus meningitis mimicking cerebral septic emboli, a case report series demonstrating injection drug use as a risk factor for development of disseminated disease. BMC Infect Dis 20, 381 (2020)

Ackley R, Roshdy D, Meredith J, Minor S, Anderson W, Capraro J, Polk C. Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections. Antimicrobial Agents and Chemotherapy Feb 2020, AAC.02313-19

Jaffa RK, Pillinger KE, Roshdy D, Isip JA, Pasquale TR. Novel developments in the treatment of acute bacterial skin and skin structure infections. Expert Opin Pharmacother. 2019 May 30:1-10.

Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients with Bacteremia and Candidemia. Clin Infect Dis. 2013 Jul 29

Barnes E, Zhao J, Giumenta A, Johnson M. The effect of an integrated health system specialty pharmacy on HIV antiretroviral therapy adherence, viral suppression, and CD4 count in an outpatient infectious diseases clinic. J Manag Care Spec Pharm 2020;26(2):95-102.

Nimmich EB, Bookstaver PB, Kohn J, Justo JA, Hammer KL, Albrecht H, Al-Hasan MN. Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence. Hosp Pharm 2017; 52(10):691-697.

Bookstaver PB, Nimmich EB, Smith TJ 3rd, Justo JA, Kohn J, Hammer KL, Troficanto C, Albrecht HA, Al-Hasan MN. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections. Antimicrobial Agents and Chemotherapy 2017; 61(9).

Hammer KL, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan, M. Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagnostic Microbiology and Infectious Disease 2017; 1(87):87-91.

Hammer KL, Stoessel A, Justo JA, Bookstaver PB, Kohn J, Derrick CB, et al. Association between chronic hemodialysis and bloodstream infections due to chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control 2016; 12(44):1611-16.

DeVaul KL, Sutton S, Steadman S, Rowen RC. Chapter 20. Upper Respiratory Tract Infections. In: Sutton S. 2nd eds. McGraw-Hill's NAPLEX Review Guide. New York, NY: McGraw-Hill; 2014.

DeVaul KL. Bug Bites, Bleeding and Biologic Preventative Methods: Emerging Pathogens. Making a Difference in Infectious Diseases Pharmacotherapy. 2013; 3(3):6-12.

Sun S, Jones RC, Fricchione M, Scardina TL, Healy D, Patel RM, Patel, SJ. Short-Duration Electronic Health Record Option Buttons to Reduce Prolonged Length of Antibiotic Therapy in Outpatients. Pediatrics. 2021 June, 147 (6) e2020034819. DOI 10.1542/peds.2020-034819

Dove ML, Preeti J, Kelleman M, Patel RM, Oster ME, et al. Multisystem Inflammatory Syndrome in Children: Survey for Early Hospital Evaluation and Management. Journal of Pediatrics. 2021 Feb 1. DOI 10.1016/j.jpeds.2020.10.026

Welch SN, Patel RM, Forrester JB, et al. Impact of antimicrobial stewardship and rapid diagnostics in children with Staphylococcus aureus bacteremia. Journal of the American College of Clinical Pharmacy. 2020 Aug; DOI 10.1002/jac5.1304

Rueter CH, Palac HL, Kociolek LK, Zheng XT, Chao YY, Patel R, Patel SM. Ideal and Actual Impact of Rapid Diagnostic Testing and Antibiotic Stewardship on Antibiotic Prescribing and Clinical Outcomes in Children with Positive Blood Cultures. Pediatric Infectious Diseases Journal. 2019 Feb;38(2):131-137.

Chao Y, Reuter C, Kociolek LK, Patel R, Zheng X, Patel SJ. Optimizing empiric therapy for Gram-negative bloodstream infections in children. J Hosp Infect. 2018 June;99 (2)145-147.

Newland J, Hersh A, Gerber J, Merideth G, Lee B, Thurm C, Metjian T, Olsen J, Thorell E, Weissman S, Brothers A, Goldman J, Yu D, Patel S, Patel R, Courter, J et al. Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): A Quality Improvement (QI) Collaborative. J Pediatric Infect Dis Soc. 2018 May;15;7(1).

Patel R, Patel S. The PICU Handbook. 1st ed. McGraw-Hill; c2018. Chapter 16, Anti-Infective Agents;p138-148. (published April 2018)

Patel R, Kociolek L, Merrick E, Reuter C, Patel S. Safety of Palivizumab Stewardship in Conjunction with Infection Prevention and Control Strategies for Healthcare-Associated Respiratory Syncytial Virus Infections. Infection Control & Hospital Epidemiology. 2018 Apr;39(4):485-487.

Kociolek L, Bovee M, Carter D, Ciolino J, Patel R, O’Donnell A, Rupp A, Zheng X, Shulman S, Patel S. Impact of a Healthcare Provider Educational Intervention of Frequency of Clostridium difficile PCR testing in Children: A Segmented Regression Analysis. J Pediatric Infect Dis Soc. 2017 June 1;6(2):142-148.

Spiekerman KM, Patel SJ, Patel R, Kociolek L. Availability, Perceptions, and Characteristics of Antibiograms Among Illinois Pediatricians. Infection Drug and Resistance. 2016 Dec;9:269-274.

Patel R, Stanford Shulman. Kawasaki Disease: A Comprehensive Review of Treatment Options. The Journal of Pharmacy and Therapeutics. 2015 Dec; 40(6):620-625.

Oral Abstracts

Lear A, Forrester J, Logston B, Laroia R, Morris L, Carlson TJ, Patel R. Initial Short versus Long Course Intravenous Antibiotics Prior to Oral Transition for Urinary Tract Infections in Neonates: A Cohort Study. Oral Abstract Presentation at the 11th Annual International Pediatric Antimicrobial Stewardship Virtual Conference.

Jones J, Barnes J, Forrester J, Morris L, Harris G, Patel R. Antimicrobial Stewardship in the NICU. Oral Abstract Presentation at the Annual Pediatric Academic Societies Virtual Meeting.

Welch S, Patel R, Morris L, Dassner A, Rozario N, Forrester J. Impact of Antimicrobial Stewardship and Rapid Diagnostics in Children with Staphylococcus aureus Bacteremia. Oral Abstract Presentation presented at ID Week, Washington, D.C.

Newland J, Hersh A, Gerber J, Merideth G, Lee B, Thurm C, Metjian T, Olsen J, Thorell E, Weissman S, Brothers A, Goldman J, Yu D, Patel S, Patel R, Courter, J et al. Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): A Quality Improvement (QI) Collaborative. Oral Abstract Presentation at ID Week, Philadelphia, PA.

Patel R. Impact of Limited Antimicrobial Stewardship on Resistance and Antibiotic Utilization. Oral Abstract Presentation at the Annual International Pediatric Antimicrobial Stewardship Conference. Kansas City, MO.

Poster Abstracts

Leonard M, Asher A, Kooken B, Polk C, Roshdy D. Critically ill patients receiving tocilizumab compared with those not receiving tocilizumab for treatment of COVID-19. IDWeek 2020 [virtual meeting].

Vanderburg H, Meredith J, Jaffa R, Aviles C, Motz B, Vrochides D, Medaris L. “Impact of an Antibiotic Stewardship Treatment and Management Algorithm for Liver Abscesses.” Anticipated poster presentation, to be presented at IDWeek 2021 Virtual Conference. October 2021

Lefemine A, Meredith J, Hammer K, Kachur K, He J, Speight C, Shahid Z. “Risk Factors and Clinical Outcomes in Patients with Hematologic Malignancies and Infections Caused by Extended Spectrum Beta-Lactamase Producing Enterobacterales.” Anticipated poster presentation, to be presented at IDWeek 2021 Virtual Conference. October 2021.

Vanderburg H, Meredith J, Jaffa R, Aviles C, Motz B, Vrochides D, Medaris L. “Impact of an Antibiotic Stewardship Treatment and Management Algorithm for Liver Abscesses.” Platform presentation presented at Research in Education and Practice Symposium. Chapel Hill, NC. June 2021.

Lefemine A, Meredith J, Hammer K, Kachur K, He J, Speight C, Shahid Z. “Risk Factors and Clinical Outcomes in Patients with Hematologic Malignancies and Infections Caused by Extended Spectrum Beta-Lactamase Producing Enterobacterales.” Platform presentation presented at Research in Education and Practice Symposium. Chapel Hill, NC. June 2021.

Wayman M, Meredith J, Welch S, Polk C. “Evaluation of Antimicrobial Prescribing Practice for Vancomycin-Resistant Enterococcus Bacteremia.” Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2020.

Lear A, Sebaaly J, Meredith J. “Assessment of Serotonin Syndrome Risk with Linezolid.” Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2020.

Meredith J., Roshdy D., Jaffa R., Medaris L., Aviles C., Cochran A., Fischer K., Sashtry V., Davidson L.  “Bridging the Divide Between Antimicrobial Stewardship and Surgical Services: Successful Use of Handshake Stewardship with Hepato-Pancreato-Biliary Surgical Services in Adult Patients at a Large Academic Medical Center.” Poster presentation presented at IDWeek 2020 Virtual Conference. October 2020.

Welch S., Meredith J., Roshdy D., Medaris L., McCarter M., McCurdy L. “Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia.” Poster presentation presented at IDWeek 2020 Virtual Conference. October 2020. Green B., Meredith J., Ackley R., McCarter M., Polk C.  “Novel Beta-lactam Beta-lactamase Inhibitors Against Alternative Antibiotics for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis Caused by Carbapenem-resistant Enterobacterales.” Poster presentation presented at IDWeek 2020 Virtual Conference. October 2020.

Keene, B. Saboori S., Meredith J., King D., Polk C., Leonard M. “The Impact of Medically Assisted Therapy for Opiate Use Disorder in Staphylococcus aureus Bacteremia Patients Within a Large Hospital System - A Retrospective Cohort Study.” Oral platform presentation presented at IDWeek 2020 Virtual Conference. October 2020.

Green EB, Meredith J, Ackley R, McCarter M, Polk C. “Targeted Multi-drug Resistant Gram-Negative Bacteria Beta-lactam Beta-lactamase Inhibitors Against Alternative Antibiotics for the Treatment of Complicated UTI and Pyelonephritis Caused by CRE: A Retrospective Analysis” Platform presentation presented at Research in Education and Practice Symposium. Chapel Hill, NC. June 2020.

Welch S, Meredith J, Roshdy D, Medaris L, McCarter M, McCurdy L. “Comparison of Daptomycin versus Vancomycin in Combination with Ceftaroline for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia” Platform presentation presented at Research in Education and Practice Symposium. Chapel Hill, NC. June 2020.

Berger O, Meredith J, Rector K, Sebaaly J. “Incidence of Drug-Drug Interactions in Hospitalized Patients on Medication for Opioid Use Disorder.” Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2020.

Roshdy D., Isip J., Hammer K., Jaffa R., Leonard M., Gajurel K., Shahid Z., Polk C. “Impact of a Novel Pharmacy Service on Antimicrobial Utilization and Mediation-Related Errors in Immunocompromised Patient Populations.” Poster presented at Atrium Health’s 10th Annual Quality and Patient Experience Sharing Day. Charlotte, NC. August 2019.

Ackley R., Roshdy R., Isip J., Minor S., Elchynski A., Anderson W., Capraro G., Polk C. “Meropenem/vaborbactam versus Ceftazidime/avibactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections.” Poster presented at Poster presented at Making a Difference in Infectious Diseases (MAD-ID). Orlando, FL. May 2019.

Elchynski A., Ackley R., Roshdy D., Minor S., Isip J., Reyenga, C., Capraro G., Anderson W., Polk C. “Meropenem/vaborbactam versus Ceftazidime/avibactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections.” Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2018.

Karabinos A., Fritz N., Isip J., Kachur E., Trivedi J., Arnall J. “Oncologic treatment evaluation of patients with HIV and aggressive lymphomas.“ Poster presented at American Society of Health-System Pharmacist Midyear Clinical Meeting. Anaheim, CA. December 2018.

Isip J., Medaris L., McCurdy, L., Kowalkowski, M., Fischer, K., Onsrud, J., Davidson L. “Successful Use of Telemedicine versus On-site Infectious Diseases Consultation After Implementation of a System-wide Antimicrobial Stewardship-led Staphylococcus aureus Bacteremia Care Bundle.” Poster to be presented at IDWeek 2018. San Francisco, CA. October 2018.

Isip J., Davidson L., Medaris L., McCurdy, L., Fischer, K., Onsrud, J. “Antimicrobial Stewardship Implementation of Staphylococcus aureus Bacteremia Bundle at Large Multi-hospital Health System.” Poster presented at Atrium Health’s 9th Annual Quality and Patient Experience Sharing Day. Charlotte, NC. June 2018.

Jaffa R., Onsrud J., Ray J., Boger M., Davidson L., Isip J. “Antimicrobial Stewardship Led Development of a System-Wide Desensitization and Graded Dose Challenge Protocol.” Poster presented at Making a Difference in Infectious Diseases (MAD-ID). Orlando, FL. May 2018.

Patel R, Forrester J. Meropenem MUE. To be presented at the 2021 ASHP Midyear Meeting

Jaffa RK, Ton M, Forrester J, Patel R, Brantley C, Campbell J, Carlson TJ, Davidson L, Patel N, Shah E, Boger S. Validation of an Adult and Pediatric Beta-Lactam Allergy Risk Stratification Tool. IDWeek 2021

Hanson S, Barnes J, Forrester J, Boyce T, Morris L, James J, Patel R. Evaluation of Vancomycin or Nafcillin for Late Onset Sepsis in the Neonatal Intensive Care Unit. Highlighted E-poster with Live Q&A. Annual 2021 Pediatric Academic Societies Virtual Meeting

Morris L, Forrester J, Patel R, Castro L, Posadas S. Pediatric Antimicrobial Utilization in Guatemala. Annual 2021 Pediatric Academic Societies Virtual Meeting

Blaiss C, Forrester J, Patel R. Evaluation of Inhaled Tobramycin Prescribing Practices in Pediatric Patients Without Cystic Fibrosis. ASHP Midyear Meeting 2019. Las Vegas, NV

Jeanne F, Dassner A, Morris L, Patel R. Impact of a Pediatric Antimicrobial Stewardship Program on Clinical Perspectives: A Pre- and Post-Implementation Survey in a Large Healthcare System. Annual International Pediatric Antimicrobial Stewardship Conference 2019. St. Louis, MO

Kiger RE, Patel R, Forrester J. Evaluation of an institutional, pharmacist-driven, pediatric vancomycin dosing and monitoring guideline. ASHP Midyear Meeting 2018. Anaheim, CA

Patel S, Reuter C, Patel R, Kociolek L, Jones R. Automated Metrics for Potential Adverse Outcomes in Pediatric Antimicrobial Stewardship. IDWeek 2017. San Diego, CA

Fricchione M, Palac H, Healy D, Patel R, Kocioloek L, Patel S. Effect of Antibiotic Duration Option Buttons in the Electronic Medical Record on Outpatient Antibiotic Prescribing Practices in Pediatrics. IDWeek 2016. New Orleans, LA

Gregerson K, Campbell L, Kociolek L, Reuter C, Patel R, Goodman D, Chao Y, Patel S. Viral Multiplex PCR Testing and Antibiotic Use in the Pediatric Intensive Care Unit. American Academy of Pediatrics National Conference 2015. Washington, D.C.

Patel R and Shulman S. Impact of Antimicrobial Stewardship on Resistance and Antibiotic Utilization in Pediatric Patients. MAD-ID Annual Conference 2012. Orlando, FL

Weedon Kathryn, MD, Patel R, PharmD, Stanford Shulman, et al,. Drug Resistance in Gram Negative Rods in Patients Admitted to a Pediatric Hospital. SHEA Annual Scientific Meeting 2011. Dallas, TX.

Close